PSMD1 and COVID-19: To support the investigation of S1 independent of viral infection it is important to note that a most recent study identified circulating S as a blood biomarker for post-acute sequalae of COVID-19, while detection of SARS-CoV-2 nucleoprotein was lesser, providing some indication that freely circulating S may be a trigger for symptoms (Swank et al., 2022).